10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today...
Day: December 29, 2025
Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to as Tri-City Surgical Centers, has...
LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026
Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS, Dec. 29, 2025 /PRNewswire/ -- LG...
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of...
2026 Calls for a Global Health System Connectivity Compact: EHR/EMR, Interoperability, and Cybersecurity Vendors Urged to Protect Continuity of Care During Conflict and Recovery
Black Book Market Research issues a global operational alert alongside the release of its 2026 "State of Global Healthcare Technology"...
Through High-Profile Ambassadors and Major Partnerships, ZetrOZ Systems Expanded Reach of sam Device in 2025
The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations to inform the public of...
Scott Leune Names 2026 Sponsors Selected to Support Dental Practice Growth and Operations
SAN ANTONIO, Dec. 29, 2025 /PRNewswire/ -- Scott Leune Education today announced its 2026 sponsors, a curated group of industry...
Healthcare Cloud Computing Market to Reach $54.72 B by 2033 | CAGR 13% | According to DataM Intelligence Report
AUSTIN, Texas and TOKYO, Dec. 29, 2025 /PRNewswire/ -- According to DataM Intelligence, the Healthcare Cloud Computing Market size reached...
New Horizon Medical Solutions Announces the Acquisition of the Applied Tissue Technologies Business Assets
New Horizon Medical Solutions acquires transparent negative pressure wound therapy device and micro grafting kit to enhance its industry-leading portfolio...
Medical Care Technologies (OTC PINK:MDCE) Achieves Global Distribution Approval from Apple’s iOS App Store
MESA, AZ / ACCESS Newswire / December 29, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a technology-driven innovator in...
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting
Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem...
Changing Healthcare Trajectories With Positive Experiences
DaVita works with others in under-resourced communities to offer individualized health engagements, break down mistrust and empower action in personal...
Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On
PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those...
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as...
Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC)...
Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates (Cosmic)...
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
With legacy overhang removed and new capital secured, management shifts focus from balance-sheet repair to disciplined growth execution. West Palm...
Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal
VANCOUVER, British Columbia, Dec. 29, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG) under the leadership of...